Axim Biotechnologies, Inc.
AXIM· OTC
AXIMAxim Biotechnologies, Inc.
Filed Aug 14, 2013 · 10-Q · 45 days after period end · 0001514955-13-000021
| Metric | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|
| Revenue | $10.83K | $10.83K | $0.00 |
| Net Income | -$29.79K | -$241.00 | $0.00 |
| EPS Diluted | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Axim Biotechnologies, Inc. · CIK 1514946 · Engraved from SEC EDGAR
ended Jun 30, 2013 · filed Aug 14, 2013 · 45 d after period end
